Physician

Richard N Medley, MD

According to 2025 Medicare claims, Richard Medley, MD (NPI: 1578550638) practices urology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Floyd, IN. This provider's primary affiliated billing organization is FIRST UROLOGY, PSC (NPI: 1922099811; TIN: 351488175) and primary practice location at 47150-6805. Medley is affiliated with the Inspire Health Partners, LLC (ACO ID: A3555), participating under the MSSP model.

Medley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,376 traditional Medicare patients, billed 8,968 HCPCS/CPT codes, and received $578,797 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 2,238 prescription claims across 798 beneficiaries totaling $505,668 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 90 claims. Open Payments data shows 87 records totaling $8,785. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $358,326 to $505,668. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $255 and ending at $434.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,570	11,160	$479,306
2016	1,798	13,314	$558,100
2017	1,744	10,890	$441,290
2018	1,767	9,988	$479,824
2019	1,786	13,410	$637,298
2020	1,537	14,655	$688,094
2021	1,555	16,322	$764,438
2022	1,495	10,911	$680,765
2023	1,485	10,226	$642,195
2024	1,376	8,968	$578,797

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	678	2,420	$358,326
2016	742	2,541	$365,685
2017	657	2,134	$343,703
2018	608	1,915	$325,525
2019	620	1,923	$284,850
2020	624	2,093	$341,909
2021	618	2,032	$396,343
2022	638	2,022	$416,414
2023	706	2,070	$400,462
2024	798	2,238	$505,668

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	69	$8,990
2016	N/R	90	$18,010
2017	N/R	59	$4,933
2018	N/R	38	$1,021
2019	N/R	23	$2,490
2020	N/R	55	$5,891
2021	N/R	159	$12,156
2022	N/R	108	$23,299
2023	N/R	158	$21,297
2024	N/R	90	$21,433

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	235	275	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	609	809	$84
84153	Psa (prostate specific antigen) measurement, total	437	526	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	591	776	$11
81003	Automated urinalysis test	768	1,130	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	322	19,674	$296,505
Gemtesa	Vibegron	183	9,586	$153,580
Mirabegron Er	Mirabegron	14	780	$8,085
Xyosted	Testosterone Enanthate	11	308	$6,819
Tamsulosin Hcl	Tamsulosin Hcl	430	34,611	$5,358

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	24	$14,044
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	20	$6,447
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	19	$582
A4332	Lubricant, individual sterile packet, each	N	N/R	27	$360

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$8,785	UROGEN PHARMA, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$2,517	Louisville URS Solutions, LLC

Explore More Providers

FAQ

What Medicare data is available for Richard N. Medley, MD?

Tedicare shows public-source Medicare data for Richard N. Medley, MD (NPI 1578550638), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard N. Medley, MD have ACO affiliation data?

Richard N. Medley, MD is shown with ACO affiliation data for Inspire Health Partners, LLC (MSSP, ACO ID A3555).

What billing organization is linked to Richard N. Medley, MD?

Richard N. Medley, MD is linked to FIRST UROLOGY, PSC (billing NPI 1922099811) in the available physician profile data.

Does Richard N. Medley, MD have Open Payments data?

Richard N. Medley, MD has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.